Related Experiment Videos
Acute and chronic pulmonary function changes in allergic bronchopulmonary aspergillosis
The American Journal of Medicine
|October 1, 1979
Summary
Pulmonary function tests in allergic bronchopulmonary aspergillosis (ABPA) patients show transient declines during acute episodes. However, most patients do not experience significant progressive functional loss after diagnosis, contrary to some literature suggestions.
Area of Science:
- Pulmonology
- Allergy and Immunology
- Medical Research
Background:
- Allergic bronchopulmonary aspergillosis (ABPA) is a hypersensitivity disorder.
- The long-term impact of ABPA on pulmonary function is not fully understood.
- Previous studies suggested progressive functional deterioration in ABPA patients.
Purpose of the Study:
- To assess pulmonary function in ABPA patients during acute episodes and over time.
- To investigate the correlation between ABPA duration and pulmonary function parameters.
- To determine if ABPA leads to significant progressive lung function loss.
Main Methods:
- Pulmonary function tests including total lung capacity, FEV1, vital capacity, FEV1:FVC ratio, and DL:CO were performed.
- Patients were evaluated during acute flares and followed over a mean of 44 months.
- Linear and multiple regression analyses were used to assess functional changes and correlations.
Main Results:
- Acute ABPA flares were associated with significant transient reductions in lung volumes and DL:CO.
- These reductions returned to baseline with steroid therapy.
- No significant progressive functional deterioration was observed in the majority of patients post-diagnosis.
- FEV1:FVC ratio remained unaltered during flares and over time.
Conclusions:
- ABPA can cause temporary declines in lung function during acute exacerbations.
- Long-term corticosteroid and bronchodilator treatment appears to prevent significant progressive lung function loss in most ABPA patients.
- Findings challenge previous notions of inevitable progressive functional decline in ABPA.